Skip to content
Artemis LabsArtemis Labs
  • Home
  • Shop
  • Research
    • Research Navigator
    • Metabolic & Incretin Signaling
    • Glucose Metabolism & Insulin Signaling
    • Vascular Biology
    • Host-Defense Peptides
    • Neuropeptide
    • Dermal & ECM Biology
    • Tissue-Repair Research
    • Secretagogues
    • Cellular & Mitochondrial Research
    • Melanocortin & Neuroendocrine Signaling
  • Blog
  • About
  • Login
  • Cart / $0.00 0
    • No products in the cart.

      Return to shop

  • 0
    Cart

    No products in the cart.

    Return to shop

Peptide Research, Research Education

MOTS-c Exercise and Metabolism Research Reviewed | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Checklist of the MOTS-c exercise and metabolism findings, marking one reported trend, three null results, and one finding that came from an engineered variant rather than the peptide
28
Aug

The preclinical MOTS-c record by species, the exercise study that reports only a trend, and the negative findings on brain entry and oral delivery, quoted as written.

Continue reading →
Posted in Peptide Research, Research Education
Quality & Testing, Research & Quality

5-Amino-1MQ Salt Forms: Chloride vs Iodide | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Side-by-side identity cards for the 5-Amino-1MQ chloride and iodide salts, each with its own PubChem CID and molecular weight, warning that pairing one salt's mass with the other's CAS number introduces a 1.47 times error
28
Aug

The chloride is CID 176507677 at 194.66 with no registered CAS. The iodide is CAS 42464-96-0 at 286.11. Mixing them creates a 1.47x molarity error.

Continue reading →
Posted in Quality & Testing, Research & Quality
Peptide Research, Research Education

5-Amino-1MQ Muscle and Metabolism Research | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Diagram unpacking the widely quoted 70 percent figure for 5-Amino-1MQ as peak torque recovering after a chemical injury in 24-month-old male mice, with no group size published in the abstract
28
Aug

What the aged-mouse muscle studies actually measured, why the ~70% figure is a recovery-after-injury result in aged male mice, and the counter-evidence usually left out.

Continue reading →
Posted in Peptide Research, Research Education
Clinical Research, Regulatory & Legal

5-Amino-1MQ Human Evidence: There Is None | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Scorecard showing zero published human trials of 5-Amino-1MQ, with three panels for the literature searches, the public trials registry and the review literature, each returning nothing
28
Aug

Zero human studies exist for 5-Amino-1MQ or any NNMT inhibitor. How that zero was verified across seven PubMed searches and a registry query, and what it means.

Continue reading →
Posted in Clinical Research, Regulatory & Legal
Peptide Research, Research Education

What Is GHK-Cu Studied For? The Research Record | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Radial map linking GHK-Cu to its research areas: skin, wound healing, hair, gene expression, copper biology, inflammation, safety and identity
28
Aug

GHK-Cu is a copper-bound tripeptide. The main scientific database describes it as a cosmetic ingredient, and two human trials in 34 years were both negative.

Continue reading →
Posted in Peptide Research, Research Education
Quality & Testing, Research & Quality

GHK vs GHK-Cu: Two Different Molecules | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Side-by-side identity panels comparing the free tripeptide GHK with the copper complex GHK-Cu, each shown with its own PubChem CID, formula, molecular weight and CAS number
28
Aug

GHK is CID 73587 at molecular weight 340.38. GHK-Cu is CID 71587328 at 402.92. Six PubChem records answer to the name GHK-Cu, and one has no copper.

Continue reading →
Posted in Quality & Testing, Research & Quality
Peptide Research, Research Education

GHK-Cu Wound Healing Research: The Full Evidence Record

Posted on August 28, 2026August 28, 2026 by Kate Cai
Bar chart of the three-arm human wound trial, in which the comparator cream reduced ulcer size while GHK-Cu and placebo did not differ, beside a panel showing the split animal record
28
Aug

The one human wound trial of GHK-Cu matched placebo. The animal record is split: rabbits and rats healed faster, guinea pigs healed slower. What that means.

Continue reading →
Posted in Peptide Research, Research Education
Peptide Research, Research Education

GHK-Cu Topical vs Systemic Evidence: What Transfers | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Split diagram comparing the GHK-Cu record for skin application, two null randomized trials, with zero controlled human studies for any other route
28
Aug

Most human GHK-Cu results come from multi-ingredient cosmetic products applied to skin. Here is why that evidence cannot be read across to research-vial material.

Continue reading →
Posted in Peptide Research, Research Education
Peptide Research, Research Education

GHK-Cu Skin Research: What the Two Human Trials Found

Posted on August 28, 2026August 28, 2026 by Kate Cai
Two cards summarising the GHK-Cu human skin trials, one with 86 participants in venous ulcers and one with 13 participants in a post-laser skin study, both null on their objective endpoints
28
Aug

GHK-Cu has two human randomized trials in 34 years. Both tested topical creams, and both were negative on every objective skin measurement. The full record.

Continue reading →
Posted in Peptide Research, Research Education
Quality & Testing, Research & Quality

GHK-Cu Sequence and Identity: CID, CAS, Mass | Artemis Labs

Posted on August 28, 2026August 28, 2026 by Kate Cai
Diagram of the GHK-Cu copper complex showing the Gly-His-Lys chain bound to copper, listed with its PubChem CID, molecular formula, molecular weight and CAS number together
28
Aug

The verified identifiers for both molecules: GHK at CID 73587, 340.38, CAS 49557-75-7, and GHK-Cu at CID 71587328, 402.92, CAS 89030-95-5.

Continue reading →
Posted in Quality & Testing, Research & Quality
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
About Artemis Labs
Research-peptide supplier with citation-dense product pages that report the published record honestly, including the negative findings. For laboratory research use only.
Latest Posts
  • 28
    Aug
    What Is Sermorelin Studied For? Research Overview | Artemis Labs Comments Off on What Is Sermorelin Studied For? Research Overview | Artemis Labs
  • 28
    Aug
    Sermorelin and the WADA Prohibited List: The Exact Wording | Artemis Labs Comments Off on Sermorelin and the WADA Prohibited List: The Exact Wording | Artemis Labs
  • 28
    Aug
    Sermorelin vs CJC-1295 vs Ipamorelin: Three Records Compared | Artemis Labs Comments Off on Sermorelin vs CJC-1295 vs Ipamorelin: Three Records Compared | Artemis Labs
  • 28
    Aug
    Sermorelin Sequence, Structure and Molecular Weight | Artemis Labs Comments Off on Sermorelin Sequence, Structure and Molecular Weight | Artemis Labs
  • 28
    Aug
    Sermorelin Safety Research: What the Trials Reported | Artemis Labs Comments Off on Sermorelin Safety Research: What the Trials Reported | Artemis Labs
Recent Comments
    Tag Cloud
    BPC-157 counter-evidence cytoprotection FAK-paxillin FDA 503A GHK-Cu HPLC independent testing KPV pentadecapeptide peptide quality purity verification retatrutide TB-500 tissue repair VEGFR2 WADA
    Categories
    • Clinical Research (19)
    • Market Analysis (1)
    • Peptide Research (73)
    • Quality & Testing (25)
    • Recovery & Tissue Repair (17)
    • Recovery Stacks (1)
    • Regulatory & Legal (35)
    • Research (5)
    • Research & Quality (26)
    • Research Education (65)
    • research-guides (1)
    • Supplier Evaluation & Quality (13)
    Archives
    • August 2026 (130)
    • May 2026 (1)
    • April 2026 (20)

    Research updates, by email

    New literature on the compounds we carry, in plain wording, with the sources linked. Plus the Citation Index: every study we cite, in one place. Nothing else.

    You're on the list. The first email is the research, not a pitch.

    Latest
    • Epitalon Epitalon
    • TB-500 10mg TB-500 10mg $40.00
    • Cartalax (AED Tripeptide) Cartalax (AED Tripeptide) $55.00
    • Glutathione 1500mg Glutathione 1500mg $100.00
    • CJC-1295 w/DAC CJC-1295 w/DAC $40.00
    Best Selling
    • Tirzepatide Tirzepatide $80.00 – $260.00Price range: $80.00 through $260.00
    • Retatrutide Retatrutide $70.00 – $240.00Price range: $70.00 through $240.00
    • Semax Semax $45.00
    • GLOW (GHK-Cu + BPC-157 + TB-500) Research Blend GLOW (GHK-Cu + BPC-157 + TB-500) Research Blend $140.00
    • PT-141 PT-141 $50.00
    Research Fields
    • Metabolic & Incretin Signaling
    • Glucose Metabolism & Insulin Signaling
    • Secretagogues
    • Tissue-Repair Research
    • Cellular & Mitochondrial Research
    • Neuropeptide
    • Melanocortin & Neuroendocrine Signaling
    • Vascular Biology
    • Dermal & ECM Biology
    • Host-Defense Peptides
    • ★ Research Navigator
    About

    Artemis Labs is a research-peptide supplier built on citation-dense product pages that report the published record honestly, including the negative findings. Our catalog is expanding — check back for new product launches.

    Latest News
    • 28
      Aug
      What Is Sermorelin Studied For? Research Overview | Artemis Labs Comments Off on What Is Sermorelin Studied For? Research Overview | Artemis Labs
    • 28
      Aug
      Sermorelin and the WADA Prohibited List: The Exact Wording | Artemis Labs Comments Off on Sermorelin and the WADA Prohibited List: The Exact Wording | Artemis Labs
    • 28
      Aug
      Sermorelin vs CJC-1295 vs Ipamorelin: Three Records Compared | Artemis Labs Comments Off on Sermorelin vs CJC-1295 vs Ipamorelin: Three Records Compared | Artemis Labs
    • 28
      Aug
      Sermorelin Sequence, Structure and Molecular Weight | Artemis Labs Comments Off on Sermorelin Sequence, Structure and Molecular Weight | Artemis Labs
    Tags
    acth-analog alpha-MSH-analog angiogenesis angiogenesis-research appetite-suppression bioregulator body composition BPC-157 cellular-senescence copper-tripeptide cyclic-heptapeptide cytoprotective dual-agonist endogenous-tripeptide gastric-protection-research gene-expression-modulator GHK GHK-Cu ghrh-analog gip-glp1-receptor Gly-His-Lys glycyl-histidyl-lysine heptapeptide incretin-agonist Khavinson-peptide longevity-research MC3R-agonist MC4R-agonist mitochondrial-research neuropeptide not-WADA-prohibited pentadecapeptide PL 14736 preclinical-only research-compound research-use-only research peptide semax SURMOUNT-trials TB-500 thymosin-beta-4-fragment tirzepatide tissue-repair-research tripeptide VEGFR2
    • Blog
    • Research Buyer FAQ
    Artemis Labs
    26803 Hanna Rd Ste 808
    Oak Ridge North, TX 77385
    United States
    Contact
    connect@artemispeptides.com
    Support is by email. We do not publish a phone number.
    Policies
    Privacy Policy · Terms · Refund Policy · Shipping Policy

    For laboratory research use only. Not for human or veterinary use, and not for any diagnostic or therapeutic purpose. Artemis Labs is not a pharmacy, a clinic or a healthcare provider, and nothing on this site is medical or veterinary advice.

    Copyright 2026 © Artemis Labs. All rights reserved.

    • Home
    • Shop
    • Research
      • Research Navigator
      • Metabolic & Incretin Signaling
      • Glucose Metabolism & Insulin Signaling
      • Vascular Biology
      • Host-Defense Peptides
      • Neuropeptide
      • Dermal & ECM Biology
      • Tissue-Repair Research
      • Secretagogues
      • Cellular & Mitochondrial Research
      • Melanocortin & Neuroendocrine Signaling
    • Blog
    • About
    • Login
    • Newsletter

    Login

    Lost your password?

    Register

    A link to set a new password will be sent to your email address.

    Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.